Coronavirus
UAE’s Abu Dhabi receives first shipment of COVID-19 medication Sotrovimab
UAE’s Abu Dhabi received its first shipment of the coronavirus Sotrovimab medication, becoming the first city globally to receive it, the media office said on a tweet on Wednesday.
The Ministry of Health and Prevention approved the emergency use of Sotrovimab in May, saying it “offers the prospect of reducing hospitalization for more than 24 hours and fatalities by as much as 85 percent when administered to patients as an early treatment for COVID-19,” the state news agency reported.
Read the latest updates in our dedicated coronavirus section.
Led by @DoHSocial, in collaboration with GlaxoSmithKline and Rafed, and following approval by @mohapuae, AbuDhabi is the first place globally to receive Sotrovimab, a new anti-Covid-19 medication shown to prevent severe illness and death in 85 per cent of cases treated early. pic.twitter.com/xGhUTXE2Bm
— مكتب أبوظبي الإعلامي (@admediaoffice) June 16, 2021
Earlier on Wednesday, the Gulf nation has registered 2,011 new COVID-19 infections, 1,976 recoveries and four deaths over 24 hours, the country’s National Emergency Crisis and Disaster Management Authority (NCEMA) reported on Wednesday.
On Tuesday, NCEMA said that a failure to comply with COVID-19 safety protocols, including wearing face masks, not social distancing and holding large gatherings have contributed to a rise in COVID-19 cases across the United Arab Emirates.
For the latest headlines, follow our Google News channel online or via the app.
Read more:
Two-thirds of Dubai’s eligible population fully vaccinated against COVID-19
Abu Dhabi approves pilot of advanced scanners to identify potential COVID-19 cases
In Oman, deadly fungal infection detected in some COVID-19 patients
With Reuters
Also Read
-
Most UAE residents think events for vaccinated people will curb COVID-19: Survey
Seven out of ten United Arab Emirates residents think opening live events only to vaccinated people will help curb the spread of COVID-19 in the ... Gulf -
UAE approves GSK’s Sotrovimab COVID-19 drug for emergency use
The UAE’s Ministry of Health announced granting the emergency use of a new effective drug for COVID-19, Sotrovimab-VIR-7831, making the UAE the first ... Coronavirus -
UAE says only COVID-19 vaccinated people with negative PCR tests can attend events
UAE officials announced only those who have received the COVID-19 vaccine, provided they present a negative result of a PCR test taken within 48 hours ... Coronavirus -
UAE’s travel sector set to bounce back after profound COVID-19 effect on industry
As the COVID-19 outbreak continues to upend global travel industries, a new report has highlighted the impact it has on the United Arab Emirate’s ... Coronavirus
